X

KURA

Kura Oncology Posts $0.92/Share Q4 Loss as KOMZIFTI Launch Delivers $2.1M in Initial Revenue

Kura Oncology reports wider Q4 loss of $0.92/share as KOMZIFTI launch generates $2.1M in first weeks; payers implement step edits…

Kura Oncology Reports $0.92 Q4 Loss Even as KOMZIFTI Debuts With $2.1M in Sales

Kura Oncology posted a $0.92 per share loss in Q4 2025 as KOMZIFTI generated $2.1M in debut sales, with payers…

Kura Oncology Inc (KURA) Q2 2022 Earnings conference

Kura Oncology Inc (NASDAQ: KURA) Q2 2022 Earnings Conference

Kura Oncology Inc (KURA) Q1 2022 Earnings conference

Kura Oncology Inc (NASDAQ: KURA) Q1 2022 Earnings Conference

Kura Oncology Inc (KURA) Kura Oncology to Report Fourth Quarter and Full Year 2021 Financial Results

Kura Oncology Inc (NASDAQ: KURA) Q4 2021 Earnings Conference

Kura Oncology, inc (KURA) Kura Oncology to Report Third Quarter 2021 Financial Results

Kura Oncology, inc (NASDAQ: KURA) Q3 2021 Earnings Conference

Kura Oncology Inc (KURA) Kura Oncology to Report Second Quarter 2021 Financial Results

Kura Oncology Inc (NASDAQ: KURA) Q2 2021 Earnings Conference